Literature DB >> 10072511

Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes.

C Beadling1, K M Druey, G Richter, J H Kehrl, K A Smith.   

Abstract

The newly recognized regulators of G protein signaling (RGS) attenuate heterotrimeric G protein signaling pathways. We have cloned an IL-2-induced gene from human T cells, cytokine-responsive gene 1, which encodes a member of the RGS family, RGS16. The RGS16 protein binds Gialpha and Gqalpha proteins present in T cells, and inhibits Gi- and Gq-mediated signaling pathways. By comparison, the mitogen-induced RGS2 inhibits Gq but not Gi signaling. Moreover, the two RGS genes exhibit marked differences in expression patterns. The IL-2-induced expression of the RGS16 gene in T cells is suppressed by elevated cAMP, whereas the RGS2 gene shows a reciprocal pattern of regulation by these stimuli. Because the mitogen and cytokine receptors that trigger expression of RGS2 and RGS16 in T cells do not activate heterotrimeric G proteins, these RGS proteins and the G proteins that they regulate may play a heretofore unrecognized role in T cell functional responses to Ag and cytokine activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072511

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Direct genetic demonstration of G alpha 13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement.

Authors:  J H Kabarowski; J D Feramisco; L Q Le; J L Gu; S W Luoh; M I Simon; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes.

Authors:  D Yowe; N Weich; M Prabhudas; L Poisson; P Errada; R Kapeller; K Yu; L Faron; M Shen; J Cleary; T M Wilkie; C Gutierrez-Ramos; M R Hodge
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  RGS4 and RGS2 bind coatomer and inhibit COPI association with Golgi membranes and intracellular transport.

Authors:  B M Sullivan; K J Harrison-Lavoie; V Marshansky; H Y Lin; J H Kehrl; D A Ausiello; D Brown; K M Druey
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

4.  Regulation of T cell activation, anxiety, and male aggression by RGS2.

Authors:  A J Oliveira-Dos-Santos; G Matsumoto; B E Snow; D Bai; F P Houston; I Q Whishaw; S Mariathasan; T Sasaki; A Wakeham; P S Ohashi; J C Roder; C A Barnes; D P Siderovski; J M Penninger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice.

Authors:  Chantal Moratz; J Russell Hayman; Hua Gu; John H Kehrl
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 6.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

7.  RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation.

Authors:  Jesse W Williams; Douglas Yau; Nan Sethakorn; Jacob Kach; Eleanor B Reed; Tamson V Moore; Judy Cannon; Xiaohua Jin; Heming Xing; Anthony J Muslin; Anne I Sperling; Nickolai O Dulin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-27       Impact factor: 5.464

Review 8.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

Review 9.  Regulation of G-protein-coupled signaling pathways in allergic inflammation.

Authors:  Kirk M Druey
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.